About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01380925

The Jewels in Our Genes Study - an African American Family Study of Breast Cancer

The research team is studying why some African American families have multiple cases of breast cancer. This study will help to better understand if there are undiscovered genes unique to African Amer...

Lead sponsor: University at Buffalo•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University at Buffalo

Collaborators

Susan G. Komen Breast Cancer Foundation

Age

18 - 100 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Black/African American
•Ever diagnosed with breast cancer
•Have at least one living blood relative ever diagnosed with breast cancer, who is also willing to participate
•Live in the U.S.

Exclusion Criteria

•Tested positive for BRCA mutations

Related studies

RECRUITINGPhase 1/2

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT07288359 · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, and more

RECRUITINGPhase 1

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

NCT04521764 · Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, and more

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

NCT06892093 · HER2-positive Breast Cancer, Diarrhea Caused by Drug, and more

RECRUITINGPhase 1

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

NCT07310420 · Advanced Breast Cancer

HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity

NCT07586215 · Breast Cancer Metastatic

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 11, 2016Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment330

Start dateOct 2010

Last updatedMay 11, 2016

Condition

Locations shown

University at Buffalo

Buffalo, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 11, 2016Data synced to Clareo: June 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions